Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Category: Cardiovascular


Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK

October 4th 2019

Approximately one-third of patients with T2DM in the UK have concomitant CVD (Diabetes Therapy)

Categories: Cardiovascular, News
Tags: Type 2 Diabetes

Categories: Cardiovascular
Tags: Type 2 Diabetes

Association of Diabetes Mellitus With Health Status Outcomes in Young Women and Men After Acute Myocardial Infarction: Results From the VIRGO Study

September 16th 2019

At baseline, young adults with diabetes mellitus had poorer health status than those without diabetes mellitus. After AMI, however, they experienced significant improvements and diabetes mellitus was not associated with worse angina, SAQ‐physical limitations, mental functioning, and quality of life, after adjustment for baseline covariates (Journal of the American Heart Association)

Categories: Cardiovascular, News
Tags: MI

Categories: Cardiovascular
Tags: MI

ESC, EASD released updated guidelines for diabetes, CVD treatment

September 3rd 2019

Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in proposing the best management strategies for an individual patient with a given condition (European Heart Journal)

Categories: Cardiovascular, News
Tags: EASD, ESC

Categories: Cardiovascular
Tags: EASD, ESC

Glucose-lowering drugs and heart failure: Implications of recent cardiovascular outcome trials in type 2 diabetes

September 1st 2019

These CVOTs data have led to guideline recommendations indicating appropriate therapy to T2DM patients with HF not at glycemic control target with metformin therapy (Diabetes Research and Clinical Practice)

Categories: Cardiovascular, News

Categories: Cardiovascular

Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis

July 30th 2019

Metformin reduces cardiovascular mortality, all-cause mortality and CV events in CAD patients. For MI patients and CAD patients without T2DM, metformin has no significant effect of reducing the incidence of CV events. Metformin has a better effect of reducing the incidence of CV events than sulfonylureas  (Cardiovascular Diabetology)

Categories: Cardiovascular, News
Tags: metformin

Categories: Cardiovascular
Tags: metformin

Predictors of cardiomyopathy in patients with type-2 diabetes mellitus with and without cardiovascular complications: A cross-sectional study

June 26th 2019

In summary, BNP and calcium levels were significantly elevated while zinc was significantly reduced in T2DM patients with cardiovascular complication. Results from the study also shown positive correlation between BNP, calcium, Troponin-I levels and blood pressure. However, further longitudinal studies required to confirm these findings (Diabetes Research and Clinical Practice)

Categories: Cardiovascular, News
Tags: Type 2 Diabetes

Categories: Cardiovascular
Tags: Type 2 Diabetes

Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes Mellitus

June 13th 2019

Compared with men developing T2DM, women with T2DM do not have a significantly higher relative increase in cardiovascular risk, but ongoing sex disparities in prescribing should prompt heightened efforts to improve the standard and equity of diabetes mellitus care in women and men (Circulation)

Categories: Cardiovascular, News
Tags: Type 2 Diabetes

Categories: Cardiovascular
Tags: Type 2 Diabetes

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

June 10th 2019

Dulaglutide could be considered for the management of glycaemic control in middle-aged and older people with type 2 diabetes with either previous cardiovascular disease or cardiovascular risk factors (Lancet)

Categories: Cardiovascular, News
Tags: Dulaglutide, REWIND, Type 2 Diabetes

Categories: Cardiovascular
Tags: Dulaglutide, REWIND, Type 2 Diabetes

Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes

June 6th 2019

In this post hoc analysis of SUSTAIN 6, once-weekly semaglutide vs placebo reduced the risk of MACE in all subjects included in the trial, regardless of gender, age, or baseline CV risk profile (Cardiovascular Diabetology)

Categories: Cardiovascular, News
Tags: semaglutide, Type 2 Diabetes

Categories: Cardiovascular
Tags: semaglutide, Type 2 Diabetes

Factors Affecting Cardiovascular Risk in Children, Adolescents, and Young Adults with Type 1 Diabetes

May 16th 2019

The frequency of cardiovascular risk factors is high in youth with T1D and associated with diabetes duration, obesity, and metabolic control (Journal of Diabetes Research)

Categories: Cardiovascular, News
Tags: children, Type 1 Diabetes, youth

Categories: Cardiovascular
Tags: children, Type 1 Diabetes, youth

Role of diabetes and insulin use in the risk of stroke and acute myocardial infarction in patients with atrial fibrillation

May 13th 2019

There is an incremental risk of ischemic stroke and MI from non-diabetics to non-insulin diabetics with the highest risk in insulin users. Protective effect of anticoagulation is attenuated with insulin use (American Heart Journal)

Categories: Cardiovascular, News
Tags: anticoagulation, atrial fibrillation, insulin

Categories: Cardiovascular
Tags: anticoagulation, atrial fibrillation, insulin

Cardiac syncope recurrence in type 2 diabetes mellitus patients vs. normoglycemics patients: the CARVAS study

April 18th 2019

T2DM patients have alterations of the autonomic nervous system, as result of cardiac autonomic neuropathy. However, T2DM diagnosis and autonomic dysfunction assessed by HRV alterations predicted VVS recurrence (Diabetes Research and Clinical Practice)

Categories: Cardiovascular, News
Tags: autonomic, autonomic function, syncope, Type 2 Diabetes

Categories: Cardiovascular
Tags: autonomic, autonomic function, syncope, Type 2 Diabetes

Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care: A First Analysis from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study

April 10th 2019

The first interim analysis from EMPRISE showed that compared with sitagliptin, the initiation of empagliflozin was associated with a decreased risk of HHF among patients with T2D as treated in routine care, with and without a history of cardiovascular disease (Circulation)

Categories: Cardiovascular, News
Tags: Empagliflozin

Categories: Cardiovascular
Tags: Empagliflozin

Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks Findings From the Swedish National Diabetes Registry

April 10th 2019

Support for preventing delaying onset (Circulation)

Categories: Cardiovascular, News
Tags: Type 2 Diabetes

Categories: Cardiovascular
Tags: Type 2 Diabetes

Dapagliflozin and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Prior Myocardial Infarction

March 19th 2019

A Sub-analysis From DECLARE TIMI-58 Trial (Circulation)

Categories: Cardiovascular, News
Tags: dapagliflozin, Type 2 Diabetes

Categories: Cardiovascular
Tags: dapagliflozin, Type 2 Diabetes

Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis

March 18th 2019

There continues to be a high prevalence of CVD among people with Type 2 diabetes and a high level of unmet need for risk factor control. This implies substantial scope for reducing the excess risk of CVD in diabetes through improved management of known risk factors (Diabetic Medicine)

Categories: Cardiovascular, News
Tags: Type 2 Diabetes

Categories: Cardiovascular
Tags: Type 2 Diabetes

Clinical factors associated with the recovery of cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus

March 11th 2019

Younger age was the most important factor in CAN recovery in subjects with type 2 diabetes, including recovery from the definite or severe stage. HbA1c reduction, body weight reduction, no concurrent micro/macroalbuminuria, and shorter duration of diabetes were also significantly associated with CAN recovery (Cardiovascular Diabetology)

Categories: Cardiovascular, News
Tags: autonomic neuropathy, Type 2 Diabetes

Categories: Cardiovascular
Tags: autonomic neuropathy, Type 2 Diabetes

Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease

February 28th 2019

Poor glycemic control is associated with coronary microvascular dysfunction amongst female diabetics presenting with chest pain and non-obstructive CAD. These findings highlight the importance of sex specific risk stratification models and treatment strategies when managing cardiovascular risk amongst diabetics (Cardiovascular Diabetology)

Categories: Cardiovascular, News
Tags: glycaemic control, microvascular

Categories: Cardiovascular
Tags: glycaemic control, microvascular

Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome

February 8th 2019

A GV cutoff value of >2.70 mmol/L was the strongest independent predictive factor for midterm MACE in patients with diabetes and ACS  (Diabetes Care)

Categories: Cardiovascular, News
Tags: glycemic variability

Categories: Cardiovascular
Tags: glycemic variability

Heart failure among people with Type 2 diabetes mellitus: real‐world data of 289 954 people from a diabetes database

February 4th 2019

Heart failure is common in diabetes mellitus, but the prevalence in the DPV is lower frequent than expected. The reason for improved metabolic control in heart failure may be intensified therapy with insulin, lipid‐lowering medication and anti‐hypertensives in this cohort (Diabetic Medicine)

Categories: Cardiovascular, News
Tags: heart failure, insulin, Type 2 Diabetes

Categories: Cardiovascular
Tags: heart failure, insulin, Type 2 Diabetes
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 14
  • Next Page »

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsors

Boehringer Ingelheim Lilly

Gold Sponsors

Sanofi DiabetesNapp DiabetesNovo NordiskAstraZeneca

Silver Sponsors

AmgenWelsh Endocrinology and Diabetes Society (WEDS)Abbott Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 Empagliflozin exenatide GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis lada liraglutide metformin microvascular mortality NAFLD NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes USA Vitamin D

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2021 Glycosmedia Partnership